Skip to main content
. 2017 Sep 4;6(9):e376. doi: 10.1038/oncsis.2017.75

Figure 6.

Figure 6

Mutant BRCA1 augments β-hCG induced EMT in BRCA1 defective cells. Immunoflourescence analysis of Vimentin and E-cadherin in control silenced (control siRNA) and BRCA1 silenced (BRCA1 siRNA#1 and BRCA1 siRNA#2) HCC1937 and SUM149 cells. “−” represents β-hCG unsupplemented cells and “+” represents exogenous β-hCG supplementated cells.